US STOCKS-Wall Street closes broadly higher on deal news, vaccine hopes

Also, Pfizer Inc rose after the drugmaker and German biotech firm BioNTech SE proposed to expand their Phase 3 pivotal COVID-19 vaccine trial to about 44,000 participants. Nvidia Corp jumped on plans to buy UK-based chip designer Arm from Japan’s SoftBank Group Corp for as much as $40 billion, in a deal set to reshape the global semiconductor landscape.

Continue Reading

HEDGE accordingly